3rd December 2021
PRESS RELEASE
BioMAdvanced Diagnostics is one of 11 companies supported by the Nantes Métropole Fonds métropolitain d’innovations en santé. In the context of the health crisis, Nantes Métropole created in spring 2020 a health innovation fund endowed with € 1 million to accelerate research and development projects to fight against Covid-19 carried out by companies or research laboratories from the Nantes area. Today, it has selected 11 new innovative projects in favor of the health of the future and 4P medicine (predictive, preventive, personalized and participative).
